All nirsevimab articles
-
NewsNew tool helps identify babies at high risk for RSV
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
-
NewsFirst results in using new tools to tackle respiratory syncytial virus
Vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent respiratory syncytial virus (RSV) among young children. Are those tools working?
